HALO is rapping up their Phase 2 program and so far the market is taking a bit of a yawn. For what its worth that program had minimal influence my deciding to invest in Halozyme. Unfortunately, management has seemed to highlight this program for quite some time and shareholders fortunes may be tied to their ability to consummate a deal by Q1 '12 (their target). I generally don't like programs like this a lot of competition, can't really take to Phase 3 much less to market yourself so your at the mercy of doing a deal. Maybe someone creative can make it work. I'd rather they'd have focused their time on getting a bunch of 5-10% royalty deals like the couple they just announced.
Market Data 
Markets 
AI
